MedPath
TGA Approval

LAMAVIR 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack (297934)

297934

LAMAVIR 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack

Hetero Australia Pty Ltd

December 13, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/7c0516280a529a1349ad31f6f1606598.pdf

Active Ingredients

abacavir sulfate

lamivudine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.